Screening for Bleeding Disorders in Children

Status Completed

Clinical Trial Summary

The investigators try to improve the screening of bleeding disorders in children by identifying symptoms, laboratory abnormalities and clinical scores discriminating patients congenital bleeding disorders in order to create a simple screening algorithm applicable in pediatrics, aiming for use in pre-anesthetic consultation and in consultation by pediatricians and general practitioners.

Clinical Trial Description

Objective : To determine simple clinical and biological factors that can improve the screening of hemostatic diseases at risk of hemorrhage in children. Method: - Retrospective inclusion of all patients <18 years referred to the CRTH in pediatric consultation for the reason of exploration of a hemorrhagic syndrome or exploration of an anomaly in the hemostasis assessment. - Data collected (by collection in the medical file): Patient data: Age, sex, personal and family history of hemorrhagic disease Clinical data: hemorrhagic symptomatology (epistaxis, gingivorrhagia, etc.) Biological data: PT, TCK, factor assay, platelet function Medical data: complete diagnosis if diagnosis of hemorrhagic disease - Scores: HEMOSTOP, PBQ, ISTH, TOSETTO score - Analyzes: calculation of the Odd Ratio, AUC, Se, Sp, VPP, VPN for different clinical / biological factors and each score. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05214300
Study type	Observational
Source	University Hospital, Montpellier
Contact
Status	Completed
Phase
Start date	December 1, 2019
Completion date	December 20, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03834727` - Characterizing the Impact and Treatment of Reproductive Tract Bleeding on Women and Post-menarchal Girls With Bleeding Disorders
Recruiting	`NCT04398628` - ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Completed	`NCT00772434` - Assessment of Bleeding Symptoms in Normal Individuals Using a Comprehensive History Phenotyping Instrument	N/A
Completed	`NCT03871452` - The Effectiveness of Ankaferd Blood Stopper in the Management of Traumatic Bleeding	N/A
Recruiting	`NCT03095625` - Role of Thromboelastography in Septic Shock	N/A
Recruiting	`NCT04600609` - Examining the Experiences of Children With Blood Disorders
Completed	`NCT02979158` - Preoperative Dual Antiplatelet Therapy: Platelet Function and Influence of Cardiopulmonary Bypass	N/A
Active, not recruiting	`NCT04912336` - Extracorporeal Life Support and Modification of Hemostasis
Terminated	`NCT05790109` - Operator and Patient Acceptance of Radiofrequency Cautery of the Biopsy Track During Percutaneous Liver, Kidney or Spleen Biopsy Procedures.	N/A
Not yet recruiting	`NCT05916469` - Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
Recruiting	`NCT06250595` - European Rare Blood Disorders Platform (ENROL)
Completed	`NCT03355742` - XIENCE 28 Global Study	N/A
Completed	`NCT03815175` - XIENCE 28 USA Study	N/A
Completed	`NCT03444324` - Adjusted Fibrinogen Replacement Strategy	Phase 3
Completed	`NCT02864875` - Early Administration of Fibrinogen in Polytraumatized Patients With Hypofibrinogenemia: a Randomized Feasibility Trial	Phase 4
Completed	`NCT04201860` - Blood Gas and Bleeding Disorders in Healthy Volunteers Exposed to Nitroglycerin and Nitrogen Compounds
Recruiting	`NCT04645199` - National Longitudinal Cohort of Hematological Diseases
Not yet recruiting	`NCT06118372` - Recombinant vWF Concentrate and ECMO	Phase 1
Active, not recruiting	`NCT04188171` - Sclerotherapy With Polidocanol Foam In The Treatment Of Hemorrhoidal Disease In Patients With Bleeding Disorders	Phase 2/Phase 3
Completed	`NCT06039904` - Protection of Knee Joints in Bleeding Disorder Patients	N/A